BeOne Medicines AGONC
NasdaqGS•Healthcare•Biotechnology
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $5.74B, growing 37.4% year-over-year. TTM net income stood at $513.02M (230.8% growth). Quarterly EBITDA was $291.05M and operating income was $249.90M. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze ONC growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters